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Abstract
Polybrominated diphenyl ethers (PBDEs) are added to plastics, polyurethane foam, and textiles as a ﬂame retardant. While PBDEs play a key role
in reducing loss of human life and property from ﬁres, these ﬂame retardants have become pervasive organic contaminants in the environment and in
the tissues of ﬁsh, birds, marine mammals, and humans. Levels of PBDEs in wildlife and humans continue to rise, raising concerns about potential
ecological and health risks associated with exposure to these chemicals. Nevertheless, there is little currently known about the toxicological effects
of PBDE exposure. Here, we examined the developmental toxicity of the PBDE congener 2,2' ,4,4' -tetrabromodiphenyl ether (PBDE 47) using
the zebraﬁsh (Danio rerio) as an ontogenetic model. Zebraﬁsh embryos were exposed continuously to dissolved phase PBDE 47 (100–5000 fg/l)
beginning 3–5 h post-fertilization (hpf). Fish treated with the highest concentrations of PBDE 47 delayed hatching, had reduced growth posthatching, and displayed an abnormal dorsal curvature of the body with ﬂexion at the hindbrain. By 96 h post-fertilization larvae exposed to PBDE
47 had signiﬁcant tachycardia, which progressed into atrioventricular block arrhythmias. Microinjection of ﬂuorescent dye into the hindbrain
ventricle revealed that cerebrospinal ﬂuid in the neural tube and brain ventricles ﬂowed more slowly in ﬁsh larvae exposed to PBDE 47, a likely
etiology for the dorsal curvature. Similar, though much less pronounced, developmental toxicity also occurred in larvae exposed to PBDE 47 only
for a 20 h period during early embryogenesis (3–23 hpf), suggesting that PBDEs incorporated in lipid of the egg are bioavailable and cause toxicity
later in life. Taken together, this work indicates that exposure to PBDE 47 can cause morphological abnormalities, impair cardiovascular function
and cerebrospinal ﬂuid ﬂow, and provides a tractable starting point for using the zebraﬁsh model to explore molecular mechanisms of PBDE toxicity.
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1. Introduction
Polybrominated diphenyl ethers (PBDEs) are a group of
brominated hydrocarbons used as a ﬂame retardant additive
in plastics, textiles, polyurethane foam, and other materials.
PBDEs are generally added to products as three commercial
mixtures (penta-BDE, octa-BDE, or deca-BDE mixtures), each
of which contains different proportions of the 209 possible
PBDE congeners that vary in their degree of bromination (Alaee
et al., 2003). While the use of PBDEs in consumer prod
ucts has helped reduce the loss of property and human life to
ﬁre, concerns have arisen recently about possible health risks
associated with PBDE exposure. These concerns stem from

accumulating evidence that levels of these persistent organic
contaminants in the environment are rising (McDonald, 2002;
Hites, 2004).
PBDEs can be transported by air and water to locations far
from their source (Wania and Dugani, 2003), and PBDE contam
ination has now been documented in environments worldwide.
This distribution includes even remote locations such as the deep
ocean and the Arctic (De Boer et al., 1998; Ikonomou et al., 2002;
Hale et al., 2003). PBDEs in the environment are bioavailable for
uptake by organisms (Ciparis and Hale, 2005), and recent studies
have established that PBDEs are present in the tissues of inver
tebrates, ﬁsh, birds, and marine mammals (Bayen et al., 2003;
F¨angstr¨om et al., 2005; Johnson-Restrepo et al., 2005; Domingo
et al., 2006; Ikonomou et al., 2006; for review see Hites, 2004).
PBDEs have even been detected in ﬁshes and marine mammals
that feed in offshore waters (De Boer et al., 1998; Ueno et al.,
2004), indicating that these chemicals have become incorporated

into pelagic and deep-sea food webs. PBDEs have also been
found in the breast milk, blood and other tissues of humans
(Schecter et al., 2003, 2005; Julander et al., 2005), signifying
that the potential risks of PBDE contamination are not limited
to wildlife. PBDEs are lipophilic, and congeners such as tetraBDE (PBDE 47) and penta-BDE (PBDE 99) can bioaccumulate
rapidly in the lipid reservoirs of organisms. As a consequence,
levels of these congeners can be considerably higher in body tis
sues than in the surrounding environment. Recent evidence has
also shown that PBDEs can be converted metabolically from
one congener to another or to hydroxylated forms not originally
included in the commercial mixtures (Kierkegaard et al., 1999;
Stapleton et al., 2004a,b; Tomy et al., 2004; He et al., 2006).
With the heavy production and use of consumer products con
taining PBDEs, levels of PBDEs in wildlife and in humans in
many parts of the world continue to rise (Ikonomou et al., 2002;
Law et al., 2003; Rayne et al., 2003; Hites, 2004; Schecter et al.,
2005; de Wit et al., 2006), elevating concerns about the poten
tial ecological and human health risks associated with PBDE
exposure (Darnerud et al., 2001; McDonald, 2002; Birnbaum
and Staskal, 2004).
The present study explored the potential developmental tox
icity of PBDEs using zebraﬁsh (Danio rerio) as a model. The
fundamental aspects of zebraﬁsh development have been the
focus of intensive research over the past decade. With this base of
knowledge, zebraﬁsh are proving increasingly useful for investi
gating mechanisms of chemical toxicity during early life stages
(Hill et al., 2005; Hinton et al., 2005). Zebraﬁsh embryos and
larvae are mostly transparent, which allows for rapid and highthroughput screens for developmental abnormalities. Typically,
zebraﬁsh embryos are exposed to chemical contaminants, often
at high concentrations, to induce clear phenotypic effects that
point to physiological and molecular pathways of toxicity. This
strategy has recently been used to identify novel mechanisms of
toxicity in ﬁsh exposed to dioxins (Bello et al., 2004), polycyclic
aromatic hydrocarbons (Incardona et al., 2005), current use pes
ticides (Haendel et al., 2004; Stehr et al., 2006) and heavy metals
(Linbo et al., 2006). Here, we used a similar approach to investi
gate the developmental toxicity of 2,2' ,4,4' -tetrabromodiphenyl
ether (PBDE 47), commonly the most concentrated PBDE con
gener found in the tissues of wildlife and humans (Hale et al.,
2001; Schecter et al., 2003; Brown et al., 2006; for review, see
Hites, 2004). In ﬁsh, PBDEs may be transferred maternally in
the lipid stores of oocytes, and offspring could be exposed to
these compounds during the earliest stages of embryogenesis.
However, potential mechanisms underlying the developmental
toxicity of PBDE 47 are still poorly understood. The zebraﬁsh
experimental system allowed us to screen for adverse responses
to a common PBDE congener that is an increasing concern for
the early life stages of freshwater and marine ﬁshes worldwide.
2. Materials and methods
2.1. Animals
Wild-type (AB strain) and nacre strain zebraﬁsh were main
tained in a breeding colony at the Northwest Fisheries Science

Center (Seattle, WA, USA) according to standard zebraﬁsh
breeding protocols (Westerﬁeld, 1995). Adults were maintained
at 26 ◦ C under a 14L:10D photoperiod in a closed ﬂow-through
system. Water supplied to the system was ﬁltered by reverse
osmosis (pH 7.5–8), and Instant Ocean® salt was added to the
water to raise the conductivity to ∼1500 fS/cm (system water).
Zebraﬁsh embryos were obtained by spawning adults in groups
containing three females and two males overnight in spawn
ing tanks. Eggs were collected and rinsed brieﬂy with system
water. Fertilized eggs were then staged under a stereomicroscope
according to the descriptions of Kimmel et al. (1995).
2.2. PBDE treatments
We obtained 2,2' ,4,4' -tetrabromodiphenyl ether (PBDE 47,
purity >99%) from ChemService, Inc. (West Chester, PA, USA).
A stock solution of PBDE 47 was prepared by dissolving
0.0165 g of PBDE 47 in 10 ml of dimethyl sulfoxide (DMSO,
Sigma). This stock solution was then diluted in system water to
create a graded series of PBDE 47 solutions. Larval zebraﬁsh
were exposed to PBDE 47 at concentrations calculated from
100 to 5000 fg/l in system water with 0.3% DMSO. The con
trol exposure consisted of system water containing 0.3% DMSO
only.
Zebraﬁsh embryos were 3–5 h post-fertilization (hpf) of age
when assigned to experimental treatments, and were exposed
to PBDE 47 or control treatments until 168 hpf. For all exper
iments, embryos and larvae were maintained at 28.5 ◦ C and
reared in sterile 24 well plates (Corning International, Corn
ing, NY, USA) at a density of four ﬁsh per 3 ml well. Treatment
solutions were changed in the wells every 48 h.
2.3. Quantiﬁcation of PBDE 47 in larval tissues
We used gas chromatography with electron capture detection
(GC-ECD) to determine the concentration of PBDE 47 present
in whole-body tissues of larval zebraﬁsh from the aqueous treat
ments described above. From 3 to 5 hpf of age, larval zebraﬁsh
were reared in system water containing PBDE 47 (100, 500, or
5000 fg/l) or control water (system water with 0.3% DMSO) in
24 well plates with four larvae per 3 ml well. Water was changed
in all wells at 48 hpf. When larvae reached 96 hpf, they were
euthanized in MS222 dissolved in system water (250 fg/ml,
tricaine methanesulfonate; Argent Chemical Laboratories, Red
mond, WA) and then rinsed brieﬂy in clean system water. Larvae
were then weighed in groups of ∼30 individuals (range, 22–37
individuals) so that the total tissue mass of each sample was
6.6 ± 0.4 mg (mean ± S.E.). These samples (n = 4 groups of
larvae per treatment) were then frozen immediately in liquid
nitrogen and stored at −80 ◦ C.
To quantify tissue levels of PBDE 47, the pooled zebraﬁsh
larvae were homogenized in deionized water and spiked with
20 fl of a 240 ng/ml solution of polycholorinated biphenyl 103
(PCB 103, w/v in hexane; purchased from Sigma–Aldrich, St.
Louis MO) as an internal standard. Hexane (1 ml) was then
added, and the homogenate was vortexed for 30 s and centrifuged
at 3000 × g for 5 min. The hexane layer was transferred to a

GC-ECD autosampler vial and diluted 1:10 with hexane. The
extraction efﬁciency of PBDE 47 was typically 90–95%. The
hexane extracts were then analyzed on a Hewlett-Packard 5890
GC equipped with a DB-5 30-m, 0.25 fM capillary column.
The GC was operated in split injection mode with a split ratio
of 8:1. The speciﬁc chromatographic conditions were as fol
lows: injection port temperature of 250 ◦ C; detector temperature
of 300 ◦ C; initial oven temperature of 90 ◦ C and then raised to
250 ◦ C at 20 ◦ C/min, then raised to 280 ◦ C at 5 ◦ C/min and held
for three additional minutes. Under these separation conditions,
the retention time of PBDE 47 was 12.16 min and PCB 103 was
8.75 min. Standard curves prepared for PBDE 47 ranged from
concentrations of 0 to 1.51 fg.
2.4. Effects of PBDE 47 on hatching, morphological
development, and survival
To determine whether exposure to PBDE 47 affected the tim
ing of hatching for zebraﬁsh, we recorded the percentage of
embryos that emerged from the chorion in each treatment well
at 48, 56, and 72 hpf. Hatching rates were calculated as the per
centage of embryos that had hatched per plate well (with four
embryos per well). Wells were replicated 24 times for each expo
sure treatment to give ﬁnal sample sizes of n = 24 replicate wells
per treatment. At 30 hpf, the rate of spontaneous movements
by the embryo in the chorion was observed under a stereomi
croscope (Nikon SMZ800) and recorded (n = 20 replicates per
treatment). These behavioral observations were blind so that the
observer did not have knowledge of the treatment.
Throughout development, embryos and larvae were exam
ined under a stereomicroscope to screen for morphological
abnormalities and record survival rates within each treatment.
The timing of formation of speciﬁc embryonic structures was
compared to an established atlas for normal zebraﬁsh develop
ment (Westerﬁeld, 1995). Fish were monitored daily from 24
to 168 hpf. Sample sizes were n = 40 replicate rearing wells per
treatment, with replicates for each treatment equally balanced
across 24 well plates.
At two points during development (72 and 96 h post
fertilization), body length of the larval ﬁsh was measured to
determine whether PBDE 47 exposure altered growth. Zebraﬁsh
were anesthetized in MS222 and photographed with a digital
camera (Spot RT camera with Spot 3.2.6 imaging software,
Diagnostic Instruments, Inc., Sterling Heights, MI) attached to
a stereomicroscope (Nikon SMZ800). The length of each ﬁsh
along the body axis from the rostrum to the base of the tail was
measured from these digital images using ImageJ software (ver
sion 1.33, National Institutes of Health, USA). Values for body
length are presented as mean body length per well. Sample sizes
were n = 24 replicate wells per treatment.
2.5. Effects of PBDE 47 on cardiac function
We quantiﬁed cardiac beat rate to determine whether expo
sure to PBDE 47 affected cardiac function in larval zebraﬁsh.
Larvae were exposed to PBDE 47 at 0, 500, or 5000 fg/l begin
ning at 3 hpf. When ﬁsh reached 72 hpf, a subset of the larvae

were lightly anesthetized in MS222 (250 fg/ml) and mounted
in 3% methyl cellulose (Sigma, St. Louis, MO, USA) on glass
slides. Videos of the heart were recorded via a digital camera
(Fire i400, Unibrain, San Ramon, CA, USA) attached to a brightﬁeld Nikon E600 compound microscope. Beat rates for both
the atrium and ventricle were later quantiﬁed from these digital
videos by a blind observer using BTV Pro Carbon 5.4.1 soft
ware. Sample sizes were n = 10–11 ﬁsh for all treatments and
developmental ages except for the highest dose of PBDE 47
(5000 fg/l) at 168 hpf. Larvae in the 5000 fg/l PBDE 47 treat
ment experienced high mortality by this age (see Section 3), so
only the few surviving ﬁsh (n = 2) could be sampled.
2.6. Imaging of cerebrospinal ﬂuid ﬂow in the neural tube
and brain ventricles
We spawned adult zebraﬁsh of the reduced-pigment nacre
strain following the protocol described above, and reared the
embryos in 5000 fg/l PBDE 47 (n = 15) or 0.3% DMSO con
trol (n = 14) solutions in 24 well plates with four ﬁsh per well.
At 144 hpf, the larvae were lightly anesthetized in MS222
(250 fg/ml) and mounted in 2% low melt agarose (LMP UltraPure agarose, Invitrogen Corp., Carlsbad, CA, USA). The
hindbrain ventricle was microinjected dorsally with a 5% solu
tion of dextran dye containing tetramethylrhodamine (70,000
MW; Molecular Probes, Inc., Eugene, OR, USA) according to
methods described by Lowery and Sive (2005). The ﬂuorescent
dye was allowed to distribute throughout the brain ventricles and
down the neural tube for 20 min, at which time we quantiﬁed
the distance down the neural tube that the dye had traveled. This
distance was measured by counting the number of segmented
skeletal muscle myotomes passed by the ﬂuorescent dye in the
neural tube. At this time, we also captured lateral ﬂuorescent
photomicrographs of the brain using a digital camera (Fire i400,
Unibrain, San Ramon, CA) mounted on a Nikon E600 micro
scope to document the dispersion of dye from the hindbrain
ventricle forward into the forebrain and midbrain ventricles. Lar
vae were then quickly ﬁxed in 4% paraformaldehyde, rinsed in
phosphate buffered saline (0.1 M), and imaged dorsally using a
confocal laser-scanning microscope (LSM 5 Pascal, Carl Zeiss,
Inc., Oberkochen, Germany).
2.7. Effects of early pulse exposures to PBDE 47
To test whether transient exposure to PBDE 47 during early
embryogenesis is sufﬁcient to cause developmental disorders,
zebraﬁsh embryos were exposed to PBDE 47 for a 20 h interval
beginning at 3 hpf. Embryos were exposed to aqueous solutions
of PBDE 47 at 100, 500, or 5000 fg/l or a vehicle control solu
tion (0.3% DMSO) in 24 well plates. After 20 h of exposure,
embryos from all treatments were removed from the PBDE 47
and control solutions, rinsed in system water for 1 min over a
plastic screen, and transferred to clean system water in new 24
well plates. The clean water was then changed every 48 h in each
well. At 168 hpf, larvae from all treatments were screened for
developmental abnormalities. Sample sizes were n = 15 wells
per treatment.

2.8. Statistical analyses
Since the hatching data failed to conform to the assumptions
of normality, we used a Kruskal–Wallis nonparametric test to
examine whether PBDE 47 affected the percentage of ﬁsh that
had hatched from the chorion at 48, 56, and 72 hpf. We then
used a Dunnett’s test to conduct pairwise comparisons between
PBDE 47 treatments and the control (Zar, 1999). The body
length of larvae at 72 and 96 hpf was compared among treat
ments using one-factor analysis of variance (ANOVA) models,
followed by Dunnett’s tests for multiple pairwise comparisons
with the control. We used repeated-measures multiple analysis
of variance (MANOVA) models to determine whether PBDE 47
affected the incidence of morphological deformities, survivorship, and the beat rate of the atrium and ventricle heart chambers.
We tested for interactions between treatment and time in these
MANOVA models using the Wilks’ lambda (Λ) test statistic.
Within each time point, pairwise comparisons between each
treatment and the control were made using Dunnett’s tests. The
ﬂow rate of ﬂuorescent dextran dye down the neural tube was
compared between PBDE 47 and control treatments using a twosample t test. Lastly, we used a Kruskal–Wallis nonparametric
test to examine whether short-term (20 h) exposure to PBDE 47
affected the frequency of morphological abnormalities, followed
by a Dunnett’s test to conduct pairwise comparisons between the
control groups and the PBDE 47 treatments. All statistical tests
were two-tailed and performed using JMP 5.1 software (SAS
Institute, Inc.).

Table 2
Effects of PBDE 47 on mean (±S.E.) percent of embryos hatched at 48, 56, and
72 h post-fertilization (hpf)
PBDE 47 dose

Control
100 fg/l
500 fg/l
1000 fg/l
2000 fg/l
5000 fg/l

% embryos hatched
48 hpf

56 hpf

72 hpf

4.2 ± 2.3
2.1 ± 1.4
3.1 ± 1.7
4.2 ± 2.5
6.3 ± 3.8
0.0 ± 0.0

67.7 ± 4.9
61.5 ± 5.2
51.0 ± 6.1
49.0 ± 7.1
34.4 ± 6.5*
43.7 ± 4.9*

96.9 ± 1.7
96.9 ± 1.7
94.8 ± 2.1
96.9 ± 1.7
93.8 ± 2.7
97.9 ± 1.4

χ2 = 3.5140,
p = 0.6213

χ2 = 17.8787,
p = 0.0031

χ2 = 2.6041,
p = 0.7607

Note: Asterisks indicate signiﬁcant difference from control (Dunnett’s test,
p < 0.05).

tion, as we found no effect of PBDE 47 on the proportion of
ﬁsh hatched at either 48 hpf or 72 hpf. This temporary delay
in hatching was not associated with any signiﬁcant develop
mental delay of embryogenesis as ﬁsh exposed to PBDE 47
followed normal developmental timing as described by Kimmel
et al. (1995). Moreover, the delayed hatching seen in PBDE 47
exposed larvae did not appear to be caused by differences in

3. Results
3.1. Whole-body tissue levels of PBDE 47
Levels of PBDE 47 in whole-body tissue homogenates of
larvae (96 hpf of age) exposed to control solution and to PBDE
47 at 100, 500, and 5000 fg/l are provided in Table 1. Tissue
concentrations of PBDE 47 varied among treatments as expected
by the graded concentrations of PBDE 47 solutions.
3.2. Exposure to PBDE 47 delays hatching and impairs
growth
Embryos exposed to PBDE 47 at concentrations of 2000 and
5000 fg/l hatched later from the chorion than embryos exposed
to the control 0.3% DMSO solution. This delay in hatching was
signiﬁcant at 56 hpf (Table 2) but appeared to be short in duraTable 1
Concentrations of PBDE 47 in whole-body tissues of zebraﬁsh (at 96 h post
fertilization) from static-renewal exposures
Treatment

Tissue concentration
(fg PBDE 47 per g wet wt)

Control
100 fg/l
500 fg/l
5000 fg/l

0.00
3.36
77.54
293.28

±
±
±
±

0.00
0.72
7.82
21.64

(fg PBDE 47 per ﬁsh)
0.000
0.001
0.016
0.060

±
±
±
±

0.000
0.000
0.002
0.005

Fig. 1. Exposure to PBDE 47 resulted in larvae with a smaller body length at
72 h post-fertilization (hpf) (A) and 96 hpf (B). Asterisks indicate signiﬁcant
difference from control. Values are presented as mean ± S.E.

the activity of embryos within the egg, since embryos exposed
to PBDE 47 at 500 and 5000 fg/l showed no difference in
the frequency of spontaneous movements within the chorion
compared to control embryos (control, 0.59 ± 0.11 movements
per min; 500 fg/l PBDE 47, 0.81 ± 0.12; 5000 fg/l PBDE 47,
0.88 ± 0.13: F2,55 = 1.6147, p = 0.2082).
Zebraﬁsh treated with PBDE 47, however, were smaller in
body length shortly after hatching (Fig. 1). At 72 hpf, this reduc
tion in body length was statistically signiﬁcant only in larvae
exposed to PBDE 47 at exposures that also delayed hatching
at 56 hpf (see Table 2). By 96 hpf, however, larvae exposed to
lower concentrations of PBDE 47 (500 fg/l and greater) were
also smaller in body size compared to controls.

3.3. PBDE 47 causes developmental defects and larval
mortality
Larvae exposed to PBDE 47 showed a consistent and
highly repeatable suite of morphological deformations. These
abnormalities included the development of an abnormal dor
sal curvature of the trunk and tail which ﬁrst appeared at
72 hpf at the highest exposure concentration and became more
pronounced over the next few days of larval development
(Fig. 2). This trunk curvature occurred in ∼100% of the lar
vae exposed to PBDE 47 at aqueous solutions of 400 fg/l or
greater (Fig. 3). However, the temporal onset of this abnor
mality was dose-dependent, with trunk malformation appearing

Fig. 2. Exposure to PBDE 47 (5000 fg/l) caused morphological abnormalities including the development of a dorsally curved tail and the failed inﬂation of the
swim bladder. Lateral view of control (A) and PBDE 47-exposed (B) larvae at 96 h post-fertilization (hpf). Lateral view of control (C and E) and PBDE 47-exposed
(D and F) larvae at 164 hpf. Higher magniﬁcation views in E and F show the failed inﬂation of the swim bladder and an unusually dark liver (arrows) and a ﬂexion
at the hindbrain (asterisk) in PBDE 47-exposed ﬁsh. Scale bars = 1 mm (A–D) and 500 fm (E and F).

Fig. 3. The frequency of abnormal dorsal tail curvature plotted against larval age
in hours post-fertilization (hpf). The occurrence of this dorsal tail curvature was
dose-dependent (treatment effect, F8,275 = 13.3271, p < 0.0001). All exposures
began at 3–5 hpf and were renewed every 48 h until larvae were 172 hpf of age.
Values are presented as mean ± S.E.

later for ﬁsh exposed to PBDE 47 at the lower concen
trations (treatment effect, F8,275 = 13.3271, p < 0.0001; time
effect, F4,272 = 21.8288, p < 0.0001; treatment × time interac
tion, Wilks’ Λ, F32,1005 = 62.0006, p < 0.0001). We did not,
however, observe any corresponding edema of the eyes or peri
cardial cavity in larvae exhibiting this tail curvature, as has
been observed in several recent studies of toxicant-induced body
axis defects in zebraﬁsh larvae (i.e., Blechinger et al., 2002;
Incardona et al., 2004; Lefebvre et al., 2004).
At the upper range of PBDE 47 exposures (400–5000 fg/l),
dorsal tail curvature was often accompanied by additional
developmental abnormalities. These changes included a fail
ure of the swim bladder to inﬂate, a discoloration of the
liver, and a ﬂexion of the head at the level of the hindbrain
(Fig. 2E and F). After the development of trunk curvature, lar
vae swam in an abnormal swirling motion. However, prior to
the appearance of the dorsal trunk curvature, larvae showed
unusually lethargic movement suggesting that there may be
more subtle physiological effects of PBDE 47 exposure exhib
ited prior to the acute morphological effects documented here.
Exposure to PBDE 47 at 500 fg/l or higher signiﬁcantly
reduced larval survival by 168 hpf relative to controls (Fig. 4).
Survival was inﬂuenced by the dose of PBDE 47, with mor
tality occurring earlier in larvae exposed to higher PBDE
47 levels (treatment effect, F8,315 = 26.5841, p < 0.0001; time
effect, F6,310 = 156.5638, p < 0.0001, treatment × time interac
tion, Wilks’ Λ, F48,1529 = 15.4581, p < 0.0001).
3.4. Exposure to PBDE 47 alters cardiac function
Exposures to PBDE 47 at 500 and 5000 fg/l had disrup
tive effects on cardiac function in larval zebraﬁsh. These effects
included a signiﬁcant increase in the beat rates (tachycardia)
of both the atrium (treatment effect, F2,19 = 1.6141, p = 0.2252;
time effect, F4,16 = 9.1732, p = 0.0005; treatment × time inter-

Fig. 4. Exposure to PBDE 47 decreased survival. The percent survivorship
of larvae exposed to PBDE 47 was highly dose-dependent (treatment effect,
F8,315 = 26.5841, p < 0.0001). All PBDE 47 exposures began at 3–5 h post
fertilization (hpf) and were renewed every 48 h. Values are presented as
mean ± S.E.

action, Wilks’ Λ, F8,32 = 2.6213, p = 0.0249) and ventricle
(treatment effect, F2,19 = 2.3504, p = 0.1224; time effect,
F4,16 = 8.6640, p = 0.0006; treatment × time interaction, Wilks’
Λ, F8,32 = 5.1803, p = 0.0003) (Fig. 5A). Tachycardia ﬁrst
appeared when larvae were between 72 and 96 hpf of age
and its extent was positively related to PBDE dose. Moreover,
at the higher PBDE 47 exposure concentration (5000 fg/l),
tachycardia progressed into arrhythmia by 120 hpf, as indi
cated by a deviation in the atrium to ventricle beat ratio
(Fig. 5B; treatment effect, F2,19 = 20.9454, p < 0.0001; time
effect, F4,16 = 12.1178, p < 0.0001; treatment × time interaction,
Wilks’ Λ, F8,32 = 5.5340, p = 0.0002). The observed arrhythmias
were typically regular and represented various degrees of atri
oventricular conduction block, i.e., atrial:ventricular beat ratios
of 4:1, 5:1 and 8:1.
3.5. PBDE 47 alters cerebrospinal ﬂuid movement in the
neural tube and brain
Live examination of PBDE 47-exposed larvae suggested
subtle alterations in circulation of blood within the hindbrain.
To explore the potential link between CNS hemodynamics,
cerebrospinal ﬂuid (CSF) dynamics, and dorsal curvature, we
assessed CSF movement after microinjection of ﬂuorescent dex
tran dye into the hindbrain ventricle (Fig. 6A). Movement of
CSF in the brain ventricles and central canal of the neural
tube was reduced in larvae exposed to PBDE 47 (5000 fg/l).
Dye in the CSF traveled signiﬁcantly slower down the cen
tral canal in PBDE-exposed larvae compared to control ﬁsh
(Fig. 6B; t = 4.4687, p < 0.0001). Movement of the dye from
the hindbrain forward into the midbrain and forebrain ven
tricles was also reduced in PBDE 47 treated ﬁsh. At 20 min
after injection, the dye had dispersed forward into the fore
brain ventricle in only 27% (4 of 15) of PBDE 47 larvae
compared to 79% (11 of 14) of the controls. Taken together,
these ﬁndings suggest that PBDE 47 exposure caused signiﬁcant

uous static-renewal PBDE 47 exposures (see Fig. 3D). Larvae
exposed to PBDE 47 for only 20 h also showed normal swim
bladder inﬂation.
4. Discussion

Fig. 5. PBDE 47 elevated heart rate and induced a cardiac arrhythmia in zebraﬁsh
larvae. (A) The atrial and ventricular rates were signiﬁcantly higher at 96 h post
fertilization (hpf) in larvae exposed to PBDE 47. This elevated cardiac rate
developed between 72 and 96 hpf. (B) The atrium:ventricle beat ratio plotted
against larva age (hpf). Zebraﬁsh larvae exposed to PBDE 47 at concentrations
of 5000 fg/l developed a cardiac arrhythmia by 144 hpf. Asterisks indicate a
statistically signiﬁcant difference from control (Dunnett’s tests, p < 0.05). All
PBDE 47 exposures began at 3–5 hpf and were renewed every 48 h, and values
are presented as mean ± S.E.

changes in CSF dynamics within the brain ventricles and neural
tube.
3.6. Transient embryonic exposure to PBDE 47 causes
subsequent toxicity
Exposure to PBDE 47 during early embryogenesis (3–23 hpf)
caused morphological abnormalities similar to those seen in
2
= 49.3188,
larvae exposed continuously to PBDE 47 (χ0.05,5
p < 0.0001) (Fig. 7A). The proportion of ﬁsh showing these
abnormalities, however, was considerably reduced with only a
20 h period of PBDE 47 exposure compared to static-renewal
exposures. Larvae treated with PBDE 47 (at concentrations of
500 and 5000 fg/l) for 20 h still developed an abnormal dor
sally curved tail by 7 dpf, however this spinal curvature was less
pronounced in even the most severely curved individuals from
the 20 h exposure (Fig. 7B) compared to larvae from the contin

Our results demonstrate that exposure to PBDE 47 during
early life can cause developmental changes in ﬁsh including
reduced growth, abnormal morphology, irregular cardiac func
tion, and altered cerebrospinal ﬂuid ﬂow. These PBDE-induced
changes were manifested early in development, with the ﬁrst
effects of PBDE 47 exposure seen as a delay in hatching and
a reduction in body size. Shortly after hatching, however, lar
vae exposed to PBDE 47 began to exhibit a consistent and
repeatable suite of morphological abnormalities that included
the development of an abnormal dorsally curved tail. This tail
curvature was ﬁrst seen at an age of 72 hpf in ﬁsh exposed to
the highest doses of PBDE 47, and became more pronounced
and common over the next several days in larvae exposed to all
PBDE 47 doses. PBDE 47 also induced cardiac abnormalities
and changes in cerebrospinal ﬂuid movement in zebraﬁsh lar
vae. Cardiac changes were ﬁrst seen as tachycardia by 96 hpf,
but progressed into atrioventricular block arrhythmias that may
have contributed to the high mortality seen in ﬁsh exposed to
the highest concentrations of PBDE 47. We also observed that
larvae exposed to PBDE 47 showed reduced movement of cere
brospinal ﬂuid in the brain ventricles and neural tube. Movement
of cerebral spinal ﬂuid plays a key role in regulating stem cell
proliferation and normal brain development (Owen-Lynch et
al., 2003; Miyan et al., 2003), and reductions in cerebrospinal
ﬂuid ﬂow have been linked to depressed neurogenesis and men
tal retardation in rodents (Mashayekhi et al., 2002). Changes
in cerebral spinal ﬂuid ﬂow in zebraﬁsh exposed to PBDE 47
may thus lead to the development of neural deﬁciencies later
in life.
The toxic developmental effects of PBDE 47 were clearly
dose-dependent, with higher doses of dissolved PBDE 47 mani
festing abnormalities earlier in development. While we primarily
reared embryos and larvae in static-renewal exposures to PBDE
47, we also found that similar, though less pronounced, morpho
logical abnormalities were manifest in zebraﬁsh larvae exposed
to PBDE 47 for only a 20 h period during early life (when larvae
were 3–23 hpf of age). Even though the embryos were reared in
clean water for all but the ﬁrst 20 h of development, these ﬁsh still
displayed toxicological effects of PBDE 47 exposure. PBDEs
are highly lipophilic, and PBDE 47 may have been incorporated
into lipid stores of the embryo during the 20 h embryonic expo
sure. Incorporated PBDE 47 may then have been bioavailable to
induce toxicological effects later in development. Further sup
port for this idea comes from our preliminary observations that
zebraﬁsh embryos exposed to PBDE 47 during other periods
of development (24–48 or 48–72 hpf) also developed a dorsal
tail curvature by 168 hpf (data not shown). In ﬁsh and other
taxa, the egg can be a signiﬁcant pathway for embryonic expo
sure to PBDEs (Petersen and Kristensen, 1998). Our results
showing that a brief exposure to PBDE 47 during embryogene
sis can cause morphological abnormalities suggest that PBDEs

Fig. 6. PBDE 47 exposure alters cerebrospinal ﬂuid movement in the brain and neural tube in zebraﬁsh larvae (144 hpf). (A) Fluorescent dextran dye was microinjected
into the hindbrain ventricle (arrow) and allowed to disseminate for 20 min into the brain ventricles and neural tube. (B) The ﬂow rate of dye down the neural tube
was signiﬁcantly greater in control ﬁsh than in larvae exposed to PBDE 47 (5000 fg/l). Values are plotted as mean ± S.E. (C and D) Representative images taken
dorsally of the brain ventricles 20 min after microinjection revealed that the ﬂuorescent cerebrospinal ﬂuid has ﬁlled the ventricles of the hindbrain (H), midbrain
(M), and forebrain (F) in control larvae (C), but had not yet reached the forebrain ventricle in PBDE 47-exposed larvae (D).

transferred maternally through the oocyte might result in devel
opmental toxicity in ﬁsh during later life.
4.1. Biological impacts and mechanisms of PBDE toxicity
PBDEs are an emerging organic pollutant (Hale et al., 2001;
McDonald, 2002; Birnbaum and Staskal, 2004), yet much
remains unknown about the biological effects of PBDE expo
sure. Studies from controlled PBDE exposures in the laboratory
have shown that PBDEs can impact neural function and behav
ior. Neonatal exposure to each of the PBDE congeners PBDE 47,
PBDE 99, PBDE 153, and PBDE 209 has been shown to cause
long-term behavioral abnormalities including elevated sponta
neous behaviors and learning/memory deﬁciencies in rodents
(Eriksson et al., 2002; Viberg et al., 2003a, 2004; Branchi et al.,
2005; Lilienthal et al., 2005). In ﬁsh, exposure to the commercial
PBDE mixture DE-71 caused delayed hatching and alterations in
behavior that included depressed swimming activity and feeding
rates in larval mummichog, Fundulus heteroclitus (TimmeLaragy et al., 2006). While behavioral changes in mummichog
were observed at DE-71 concentrations as low as 0.001 fg/l, a
delay in hatching was only seen at the highest DE-71 concen

tration tested (100 fg/l). Although the mechanisms underlying
these defects are unclear, as are the precise cellular or molec
ular targets of PBDEs, recent studies have focused on thyroid
hormone function and cholinergic pathways in the CNS. PBDEs
depressed plasma levels of the thyroid hormone thyroxine (T4 )
in a variety of vertebrates including rodents (Hallgren et al.,
2001; Hallgren and Darnerud, 2002), birds (Fernie et al., 2005),
and ﬁsh (Tomy et al., 2004). In rodents, PBDE exposure has
also been shown to alter cholinergic functioning in neural tis
sues (Dufault et al., 2005). Rats exposed to PBDEs had fewer
nicotinic acetylcholine receptors in the hippocampus, possibly
contributing to impaired learning and memory (Viberg et al.,
2002, 2003b, 2005).
Are there potential links between these neurotoxic or
endocrine-disrupting effects of PBDEs and our observed effects
of PBDE 47 during zebraﬁsh development? Overall, two lines of
evidence suggest that the most pronounced effects of PBDE 47
described here arise from impacts on neural development. First,
dorsal curvature of the body axis can be secondary to defects in
cardiac function (Incardona et al., 2004, 2006), most likely due
to the links between systemic blood pressure, CSF secretion, and
maintenance of brain ventricle volume (Carey and Vela, 1974;

Fig. 7. Developmental toxicity of PBDE 47 in zebraﬁsh exposed for only a
20 h period during early embryogenesis (3–23 hpf). (A) The percent of larvae
showing morphological abnormalities at 168 hpf in larvae exposed to PBDE
47 (500 and 5000 ng/l). Statistically signiﬁcant differences from control are
indicated by asterisks (Dunnett’s tests, p < 0.05). Percentages are provided in
parentheses above each bar, and values are presented as mean ± S.E. (B) The
most severely impacted larvae (age 164 hpf) exposed to PBDE 47 (5000 fg/l)
from 3 to 23 hpf exposure developed an abnormal dorsally curved tail, but still
showed normal inﬂation of the swim bladed (arrows). Scale bar = 1 mm.

Weiss and Wertman, 1978; Deane and Segal, 1979). However,
in cases of cardiac dysfunction arising from speciﬁc genetic
lesions or chemical cardiotoxicity, dorsal curvature is clearly
preceded by reduction in cardiac output. With PBDE 47 expo
sure, dorsal curvature preceded the onset of tachycardia, and
even in early phases of tachycardia (before the development of
arrhythmia) there were no signs of reduced cardiac output (e.g.
edema). Moreover, larvae with dorsal curvature due to a pri
mary cardiac defect do not develop ﬂexion at the hindbrain (see
Fig. 3F; Incardona et al., 2004, 2006). Instead, the reduced move
ment of ﬂuorescent dextran through the CSF suggests a primary
neural defect that leads to altered hydrostatic pressure in the
CNS. Severe reductions in cardiac output during ﬁsh develop
ment result in a failure of brain ventricle expansion (Schier et al.,
1996; Lowery and Sive, 2005), while severe reductions in CSF
ﬂow result in hydrocephaly (Kramer-Zucker et al., 2005). The

reduced CSF ﬂow in the absence of hydrocephaly in PBDE 47
exposed larvae suggests that CSF production or secretion may
be impacted, possibly due to local circulation changes within the
hindbrain. In this regard, it is notable that PBDE 47-exposed lar
vae resemble the zebraﬁsh brain mutant turned on, which shows
a mildly reduced hindbrain ventricle and develops dorsal body
curvature and ﬂexion at the hindbrain by 6 dpf (Schier et al.,
1996).
Second, the timing of the cardiac effects of PBDE 47 expo
sure is consistent with changes in the autonomic regulation of the
heart. In zebraﬁsh embryos prior to about 72 hpf, cardiac func
tion (e.g. heart rate, contractility) is driven by intrinsic processes,
and does not come under extrinsic inﬂuence from autonomic
input or nitric oxide signaling until later in the larval period
(Fritsche et al., 2000; Pelster et al., 2005; Schwerte et al., 2006).
Chemicals that directly impact myocardial targets generally pro
duce cardiac dysfunction in the range of 24–48 hpf, including
PAHs (Incardona et al., 2004, 2005, 2006), dioxins (Antkiewicz
et al., 2005), and cardioactive pharmaceuticals (Langheinrich et
al., 2003; Milan et al., 2003). Heart rate in zebraﬁsh ﬁrst becomes
sensitive to externally applied adrenergic agonist at 72 hpf, and
externally applied acetylcholine at 96 hpf (Schwerte et al., 2006).
However, the M2 muscarinic acetylcholine receptor is expressed
in the developing heart by 36 hpf, and morpholino knockdown
of this receptor produced tachycardia by 72 hpf (Hsieh and Liao,
2002). Therefore a tachycardia appearing at 96 hpf could result
from reduced cholinergic input or an excess of adrenergic input.
PBDE 47 therefore potentially alters the development of the
vagal or sympathetic inputs to the heart. However, a preliminary
analysis of islet1-GFP transgenic zebraﬁsh larvae (Higashijima
et al., 2000) exposed to PBDE 47 showed no gross changes
in either the vagal innervation of the heart or the distribution of
vagal motor neuron cell bodies in the hindbrain (data not shown).
We therefore cannot rule out a neurochemical effect of PBDE 47
on neurotransmitter levels or receptor activity (either cholinergic
or adrenergic), a postganglionic effect on the heart (i.e., cardiac
acetylcholine receptors), or subtle alterations in development of
autonomic preganglionic ﬁbers, particularly those arising from
the hindbrain.
In zebraﬁsh, the thyroid gland differentiates between 40 and
70 hpf (Rohr and Concha, 2000; Alt et al., 2006) and is func
tional by 72 hpf (Brown, 1997), but the roles of thyroid hormone
during zebraﬁsh development are otherwise not well character
ized. Nevertheless, other than lack of swim bladder inﬂation,
there is little overlap between the effects of PBDE 47 exposure
and treatment of zebraﬁsh embryos with goitrogens or the phe
notype of mutants that lack normal thyroid gland development
(Liu and Chan, 2002; Elsalini and Rohr, 2003). It is impor
tant, however, to note that exposure to other thyroid-disrupting
contaminants (i.e., PCBs) rarely produces effects entirely con
sistent with genetically mediated or goitrogen-induced thyroid
hormone deﬁciencies (Brown et al., 2004; Zoeller et al., 2000).
Therefore, in the absence of speciﬁc assays for thyroid function,
we cannot rule out an endocrine-disrupting effect of PBDE 47.
Additional studies are needed to fully identify the mecha
nisms responsible for the developmental toxicity of PBDE 47.
Yet by identifying a repeatable suite of morphological and phys

iological defects caused by PBDE 47 exposure, we now provide
a starting point for future studies to investigate whether these
toxic effects result from PBDEs impacting cholinergic function,
thyroid pathways, or some other physiological mechanism. It is
likely that considerable insight may be gained by a combination
of pharmacological studies and a more detailed neuroanatom
ical analysis, a process that should be greatly enhanced by the
tools available with the zebraﬁsh model.
4.2. Relevance to exposure to PBDE contaminants in the
wild
In the current study, zebraﬁsh embryos and larvae were
exposed to PBDE 47 via water, and thus the primary routes
for PBDE 47 uptake by larvae were likely through the gills into
blood circulation or through direct dermal absorption. In the
natural environment, however, PBDEs do not reach high con
centrations in surface waters due to their high lipophilicity, and
thus the main route of exposure to PBDEs is likely dietary. The
lipophilic properties of PBDEs cause them to sequester in lipidrich animal tissues. Similar to other lipophilic contaminants such
as PCBs and DDT, PBDEs have been shown to bioaccumulate
with increases in trophic level (Law et al., 2003). For juvenile and
adult ﬁsh, the main exposure route to PBDEs is thus likely to be
through consumption of PBDE-contaminated prey. At the ear
liest stages of development, however, maternal-transfer through
lipid stores of the egg can be a signiﬁcant pathway for embryonic
exposure to lipophilic contaminants such as PBDEs.
The concentrations of PBDE 47 required to induce a con
sistent and reproducible phenotype in zebraﬁsh over this short
developmental period were high, especially relative to the tissue
concentrations that have been recorded in people and animals
in the wild. Using our measured whole-body concentrations of
PBDE 47 (Table 1) and known whole-body lipid masses for
larval zebraﬁsh (Petersen and Kristensen, 1998), we calculate
that the body burden of PBDE 47 in zebraﬁsh larvae from the
500 fg/l PBDE 47 treatment was ∼2,090,909 ng PBDE 47 g−1
lipid. In the wild, measurements of PBDE levels in eggs and
embryos of wildlife are generally lacking. However, some of
the highest total PBDE levels recorded in adult marine mammals
(4950 ng PBDE per gram lipid; She et al., 2002), birds (7510 ng
PBDE per gram lipid; Norstrom et al., 2002), and ﬁshes (7200 ng
per gram lipid; Hale et al., 2001) (for review, see Hites, 2004)
are considerably lower than the tissue levels required to cause
developmental toxicity here. It is important to note, however,
that this study was a phenotypic screen ofﬁsh embryos exposed
to a common PBDE congener and was therefore not designed to
evaluate toxicological responses at low, environmentally real
istic exposure concentrations. In similar work, Hornung et al.
(1996) did not observe any toxicity effects of PBDE 47 when
the compound was injected into rainbow trout (Oncorhynchus
mykiss) eggs at concentrations up to 12 fg/g, suggesting that
environmental PBDEs may not yet reach the levels necessary to
produce developmental defects in wild ﬁsh species.
Furthermore, we administered only PBDE 47 to develop
ing ﬁsh embryos since this congener is often the most common
PBDE compound detected in animal tissues (Hale et al., 2001;

Brown et al., 2006; Ikonomou et al., 2006; for review, see Hites,
2004). Animals in the wild, however, are exposed to a suite of
PBDE forms and other PBDE congeners may be more potent in
their biological effects. Recent evidence indicates that PBDEs
can be biotransformed from one congener to another and to
hydroxylated forms (Kierkegaard et al., 1999; Stapleton et al.,
2004a,b; Tomy et al., 2004), and future work should explore
whether these hydroxylated PBDEs could in part mediate the
toxicity of PBDE 47 seen in larval zebraﬁsh.
5. Conclusions
Here, we provide the ﬁrst evidence that embryonic exposure
to PBDE 47 can result in the development of morphological,
cardiac and neural deﬁcits that impair survivorship for ﬁsh lar
vae. The concentration of PBDE 47 required to cause acute
developmental toxicity was considerably higher than the tis
sue concentrations that have been record in animals and people
to date. Nevertheless, now that we have identiﬁed consistent
developmental alterations caused by PBDE 47 exposure, future
studies have a foundation for exploring the cellular and phys
iological mechanisms by which PBDE 47 exerts these effects.
Furthermore, this developmental toxicity was seen in zebraﬁsh at
high doses of PBDE 47 under controlled laboratory conditions,
and more work is needed to examine whether similar develop
mental impacts might occur in native species under long-term
exposure to lower PBDE concentrations.
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Darnerud, P.O., Eriksen, G.S., Jóhannesson, T., Larsen, P.B., Viluksela, M.,
2001. Polybrominated diphenyl ethers: occurrence, dietary exposure, and
toxicology. Environ. Health Perspect. 109 (Suppl. 1), 49–68.
Deane, R., Segal, M.B., 1979. The effect of vascular perfusion of the choroid
plexus on the secretion of cerebrospinal ﬂuid. J. Physiol. 293, 18P–19P.
De Boer, J., Wester, P.G., Klamer, H.J.C., Lewis, W.E., Boon, J.P., 1998. Do
ﬂame retardants threaten ocean life? Nature 394, 28–29.
de Wit, C.A., Alaee, M., Muir, D.C.G., 2006. Levels and trends of brominated
ﬂame retardants in the Arctic. Chemosphere 64, 209–233.
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Schecter, A., Päpke, O., Tung, K.C., Joseph, J., Harris, T.R., Dahlgren, J., 2005.
Polybrominated diphenyl ether ﬂame retardants in the U.S. population: cur
rent levels, temporal trends, and comparison with dioxins, dibenzofurans,
and polychlorinated biphenyls. J. Occup. Environ. Med. 47, 199–211.
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